UNIT 22F.9 Differentiation of Multipotent Adult Progenitor Cells into Functional Endothelial and Smooth Muscle Cells

  1. Aernout Luttun1,
  2. Jeffrey J. Ross1,
  3. Catherine Verfaillie1,
  4. Xabier L. Aranguren2,
  5. Felipe Prósper2

Published Online: 1 DEC 2006

DOI: 10.1002/0471142735.im22f09s75

Current Protocols in Immunology

Current Protocols in Immunology

How to Cite

Luttun, A., Ross, J. J., Verfaillie, C., Aranguren, X. L. and Prósper, F. 2006. Differentiation of Multipotent Adult Progenitor Cells into Functional Endothelial and Smooth Muscle Cells. Current Protocols in Immunology. 75:F:22F.9:22F.9.1–22F.9.31.

Author Information

  1. 1

    University of Minnesota, Minneapolis, Minnesota

  2. 2

    Clínica Universitaria University of Navarra, Pamplona, Spain

Publication History

  1. Published Online: 1 DEC 2006
  2. Published Print: NOV 2006


Stem cells are not only a promising in vivo tool for the treatment of diseases characterized by irreversible tissue damage, but can also be exploited as in vitro systems to study the conditions required to generate molecularly and functionally defined cell types. Constructing functional arteries with luminal arterial endothelial cells stabilized by a medial layer of smooth muscle cells is one of the challenges of regenerative medicine. This unit describes the conditions for generating endothelial and smooth muscle cells from multipotent adult progenitor cells (MAPCs). It elaborates on the importance of certain parameters, e.g., quality control of the stem cell population used, serum lot variations, seeding density, use of appropriate cytokines, critical to obtaining high differentiation efficiencies. It further focuses on the molecular and functional characterization of the obtained cell types.


  • stem cells;
  • endothelial cells;
  • smooth muscle cells;
  • differentiation;
  • culture;
  • cytokines;
  • functionality